Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases

NCT07283315 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Paediatric B Cell-related Autoimmune Diseases
Autoimmune Diseases
CAR

Interventions

BIOLOGICAL: anti-CD19/BCMA CAR NK cells (KN5601-K)

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]